PONIARD PHARMACEUTICALS, INC. - FORM 10-K - EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - March 30, 2011

Attached files

file filename
10-K - ANNUAL REPORT ON FORM 10-K - PONIARD PHARMACEUTICALS, INC.d10k.htm
EX-32.2 - SECTION 906 CFO CERTIFICATION - PONIARD PHARMACEUTICALS, INC.dex322.htm
EX-32.1 - SECTION 906 CEO CERTIFICATION - PONIARD PHARMACEUTICALS, INC.dex321.htm
EX-31.2 - SECTION 302 CFO CERTIFICATION - PONIARD PHARMACEUTICALS, INC.dex312.htm
EX-31.1 - SECTION 302 CEO CERTIFICATION - PONIARD PHARMACEUTICALS, INC.dex311.htm

Exhibit 23.1

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

We consent to the incorporation by reference in the following Registration Statements:

 

  •  

Registration Statements (Form S-3 Nos. 333-159253, 333-134480 and 333-123672) of Poniard Pharmaceuticals, Inc.;

 

  •  

Registration Statements (Form S-8 Nos. 333-143965, 333-135861, 333-126209, 333-115729, and 333-89476) pertaining to the Amended and Restated 2004 Incentive Compensation Plan; and

 

  •  

Registration Statements (Form S-8 Nos. 333-41764, 333-32583, 33-43860, 33-46317 and 33-87108) pertaining to the Restated 1994 Stock Option Plan of Poniard Pharmaceuticals, Inc.

of our report dated March 30, 2011, with respect to the consolidated financial statements of Poniard Pharmaceuticals, Inc., included in this Annual Report (Form 10-K) for the year ended December 31, 2010.

/s/ Ernst & Young LLP

Palo Alto, California

March 30, 2011

PONIARD PHARMACEUTICALS, INC. Reports